US Patent 8722867 Gene therapy vectors and cytosine deaminases
Patent 8722867 was granted and assigned to Tocagen on May, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 2 Dec, 2023
Golden AI
Edits made to:
Article (+251 characters)
Article
Patent abstract
This disclosure provides modified cytosine deaminases (CDs). The disclosure further relates to cells and vector expressing or comprising such modified CDs and methods of using such modified CDs in the treatment of disease and disorders.
Edits on 25 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Christopher R. Logg0
Douglas J. Jolly0
Harry E. Gruber0
Omar D. Perez0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08722867 Gene therapy vectors and cytosine deaminases US Patent 8722867 Gene therapy vectors and cytosine deaminases
Infobox
Patent Number
08722867
Patent Number
8722867
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08722867 Gene therapy vectors and cytosine deaminases
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08722867
Date of patent
May 13, 2014
Patent application number
13072705
Date Filed
March 26, 2011
Patent primary examiner
Find more entities like US Patent 8722867 Gene therapy vectors and cytosine deaminases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.